Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Sales | 502 | 858 | 1,544 | 1,477 | 1,755 |
| Cost of Goods | 454 | 743 | 928 | 738 | 745 |
| Gross Profit | 48 | 115 | 616 | 739 | 1,010 |
| Operating Expenses | 8,042 | 11,108 | 9,413 | 6,828 | 6,284 |
| Operating Income | -7,540 | -10,250 | -7,869 | -5,351 | -4,529 |
| Interest Expense | 58 | 30 | 31 | 36 | 40 |
| Other Income | 142 | -4,084 | 5,612 | 28 | 42 |
| Pre-tax Income | -7,456 | -14,364 | -2,288 | -5,359 | -4,527 |
| Net Income Continuous | -7,456 | -14,364 | -2,288 | -5,359 | -4,527 |
| Net Income | $-7,456 | $-14,364 | $-2,288 | $-5,359 | $-4,527 |
| EPS Basic Total Ops | -0.48 | -0.96 | -0.15 | -0.37 | -0.32 |
| EPS Basic Continuous Ops | -0.48 | -0.96 | -0.15 | -0.37 | -0.32 |
| EPS Diluted Total Ops | -0.48 | -0.96 | -0.15 | -0.37 | -0.32 |
| EPS Diluted Continuous Ops | -0.48 | -0.96 | -0.15 | -0.37 | -0.32 |
| EBITDA(a) | $-7,032 | $-9,816 | $-7,440 | $-4,916 | $-4,103 |